Skip to main content

Table 2 Medical resource utilization and prescribed medications in 2008 (France)

From: Prescribed therapy for asthma: therapeutic ratios and outcomes

 

R = 0%

0% < R < 50%

R ≥ 50%

p-value

All patients

    

Number of patients

1,176

1,358

2,053

 

Age, years (mean)

28.1

28.4

29.5

<0.0001

Gender, female (%)

54.7%

53.5%

55%

0.66

Number of GP visits (mean)

5.3

6.5

5.6

<0.0001

Prescribed therapy (a)

    

Number of respiratory medication units (mean)

5.1

18.6

8.7

<0.0001

Patients with ≥ 1 prescription of LABA-ICS fixed combination (%)

-

71.2%

81.2%

<0.0001

Number of short-acting beta agonists units (mean)

2.9

6

1.8

<0.0001

Systemic corticosteroids

    

Patients with ≥ 1 prescription (%)

21.9%

36.1%

30.5%

<0.0001

Number of units (mean)

0.6

1.2

0.8

<0.0001

Antibiotics (b)

    

Patients with ≥ 1 prescription (%)

46.5%

55.7%

53%

<0.0001

Number of units (mean)

1.3

2.1

1.7

<0.0001

Patients with at least 6 prescriptions of respiratory medications in 2008

Number of patients

367

1,153

1,152

 

Systemic corticosteroids

    

Patients with ≥ 1 prescription (%)

21%

36%

32.1%

<0.0001

Number of units (mean)

0.7

1.2

1

0.05

Antibiotics (b)

    

Patients with ≥ 1 prescription (%)

43.9%

55.3%

52%

0.0006

Number of units (mean)

1.3

2

1.8

<0.0001

  1. (a)Canisters for inhaled therapy and packages for oral therapy in France.
  2. (b)Beta-lactams, cephalosporins (first to third generation), macrolides and fluoroquinolones.